
Hepatocellular carcinoma is the most common type of liver cancer. It is an aggressive (fast-growing) cancer that most commonly affects persons with severe liver disease, such as cirrhosis. People with HCC are increasingly being diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), which can develop to cirrhosis.
Tumours may not present symptoms in their early stages. However, as HCC proceeds, you may notice the following:
Causes
Risk Factors
The following conditions enhance your risk of developing HCC:
Recent developments in Malaysian hepatocellular carcinoma (HCC) treatment have offered promising treatments that improve patient outcomes.
These discoveries demonstrate how Malaysia actively advances the treatment of HCC by participating in international clinical research and developing novel medicines.
There are various ways to lower your chances of having HCC. You can do:
Surgery: The surgical treatments for HCC are hepatectomy (removal of the diseased section of the liver) or liver transplantation.
Ablation therapy: This involves the use of a specialised needle to burn malignancies. The needle can direct highly hot energy (microwaves or radiofrequency waves) or extremely cold.
Embolisation: This is the process of implanting a material directly into the arteries that supply the tumour, blocking blood flow.
Radiation therapy: Providers may recommend radiation therapy to treat tiny cancers that cannot be removed surgically or destroyed through ablation.
Immunotherapy: Immunotherapy drugs are also used to treat advanced HCC. They help your immune system recognise and combat cancer cells.
Cost Start From USD 15000 - USD 50000Explore Options
Targeted therapy: These medications treat advanced HCC. This medication inhibits the signal that tells cancer cells to continue growing.
Cost Start From USD 2000 - USD 10000Explore Options
Hepatocellular Carcinoma (HCC) rehabilitation treatments aim to increase quality of life, accelerate physical recovery, and minimise therapeutic side effects. Here are the main rehabilitation alternatives for HCC patients:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.

Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Malaysia:
In Malaysia, liver transplantation is a viable treatment option for HCC, primarily in instances that are still in the early stages. Because there aren't many deceased donors, liver transplants using living donors are frequently performed; when people are properly chosen using predetermined medical standards, they can have positive results.
The effectiveness of HCC treatment in Malaysia depends largely on the stage at diagnosis. Early-stage patients have better outcomes with options like surgery and ablation, while late-stage cases face limited success. Overall, survival rates remain modest due to late detection.
Improvements in early detection and therapy choices lead to better treatment outcomes for hepatocellular carcinoma (HCC) in Malaysia. Survival rates are steadily rising due to increased access to medicines, including liver transplantation, ablation, and tailored therapy, and there is hope for more advancements with more research and better healthcare programs.
Yes, lifestyle changes include:
In Malaysia, hepatocellular carcinoma (HCC) is a frequent malignancy, especially among men. Due in large part to the high prevalence of liver illnesses like hepatitis B and C, which raise the risk of liver cancer, it is one of the top causes of cancer-related fatalities in the nation.
Hepatocellular carcinoma (HCC) patients' quality of life (QoL) in Malaysia is affected by several variables, such as the stage of the disease, the type of treatment used, and the underlying liver function. Studies have shown that physical symptoms and psychological stress may cause patients with advanced liver disease or those receiving intense therapies to have lower quality of life (QoL) scores. However, these effects can be lessened with early discovery and efficient therapy, underscoring the significance of prompt diagnosis and all-encompassing care.